Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
Condition(s):Primary Progressive Multiple Sclerosis; Multiple Sclerosis, Secondary ProgressiveLast Updated:October 27, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Primary Progressive Multiple Sclerosis; Multiple Sclerosis, Secondary ProgressiveLast Updated:October 27, 2014Unknown status
Condition(s):Colorectal NeoplasmsLast Updated:January 14, 2020Terminated
Condition(s):Acute BronchitisLast Updated:May 1, 2017Unknown status
Condition(s):Acute TonsillitisLast Updated:May 1, 2017Unknown status
Condition(s):Acute Exacerbation of Chronic BronchitisLast Updated:April 28, 2017Unknown status
Condition(s):Squamous Cell Carcinoma of EsophagusLast Updated:November 8, 2021Completed
Condition(s):Covid19Last Updated:September 9, 2021Unknown status
Condition(s):Knee OsteoarthritisLast Updated:July 15, 2021Completed
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:June 23, 2016Completed
Condition(s):Increased InsulinLast Updated:September 14, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.